Peer Review reports
From: Synthesis and antitumor activity of dolutegravir derivatives bearing 1,2,3-triazole moieties
| Original Submission | ||
|---|---|---|
| 4 Jun 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 3 Aug 2023 | Author responded | Author comments - Longfei Mao |
| Resubmission - Version 3 | ||
| 3 Aug 2023 | Submitted | Manuscript version 3 |
| 6 Oct 2023 | Reviewed | Reviewer Report |
| 15 Feb 2024 | Reviewed | Reviewer Report |
| 7 Mar 2024 | Author responded | Author comments - Longfei Mao |
| Resubmission - Version 4 | ||
| 7 Mar 2024 | Submitted | Manuscript version 4 |
| 31 Mar 2024 | Reviewed | Reviewer Report |
| 17 Apr 2024 | Author responded | Author comments - Longfei Mao |
| Resubmission - Version 5 | ||
| 17 Apr 2024 | Submitted | Manuscript version 5 |
| 19 Apr 2024 | Author responded | Author comments - Longfei Mao |
| Resubmission - Version 6 | ||
| 19 Apr 2024 | Submitted | Manuscript version 6 |
| 27 Apr 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 29 Apr 2024 | Editorially accepted | |
| 7 May 2024 | Article published | 10.1186/s13065-024-01205-3 |
You can find further information about peer review here.